Local Institution - 2113 — Detroit, Michigan

Local Institution - 2113 is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 2113 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumors, MET Gene Alterations.

Sponsors: Turning Point Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Detroit

Browse all research sites in Michigan · View every site in Detroit

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 2113?

Local Institution - 2113 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 2113 conducted?

Local Institution - 2113 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumors, MET Gene Alterations.

Is Local Institution - 2113 accredited by Crixeo Clinical Trials?

Local Institution - 2113 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 2113?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.